Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Jean-François Gestin"'
Autor:
Maarten Vanermen, Mathilde Ligeour, Maria-Cristina Oliveira, Jean-François Gestin, Filipe Elvas, Laurent Navarro, François Guérard
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 9, Iss 1, Pp 1-57 (2024)
Abstract Background 211At-radiopharmaceuticals are currently the subject of growing studies for targeted alpha therapy of cancers, which leads to the widening of the scope of the targeting vectors, from small molecules to peptides and proteins. This
Externí odkaz:
https://doaj.org/article/16bd85d03400448886c43452b4e5a9fc
Publikováno v:
Pharmaceutics, Vol 13, Iss 6, p 906 (2021)
Among all existing radionuclides, only a few are of interest for therapeutic applications and more specifically for targeted alpha therapy (TAT). From this selection, actinium-225, astatine-211, bismuth-212, bismuth-213, lead-212, radium-223, terbium
Externí odkaz:
https://doaj.org/article/71e01208e20a4ebd8aa898559bef0639
Autor:
Françoise Léost, Grégory Delpon, Emmanuel Garcion, Jean-François Gestin, Mathieu Hatt, Vincent Potiron, Latifa Rbah-Vidal, Stéphane Supiot
Publikováno v:
Bulletin du Cancer. 109:1088-1093
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e71ce796fd8d81003a8ad21195ac372f
https://doi.org/10.1016/j.bulcan.2022.06.005
https://doi.org/10.1016/j.bulcan.2022.06.005
Autor:
Gilles Montavon, François Guérard, Jean-François Gestin, Nicolas Galland, Romain Eychenne, Lu Liu, Clémence Maingueneau
Publikováno v:
Accounts of Chemical Research
Accounts of Chemical Research, American Chemical Society, 2021, 54 (16), pp.3264. ⟨10.1021/acs.accounts.1c00327⟩
Accounts of Chemical Research, 2021, 54 (16), pp.3264. ⟨10.1021/acs.accounts.1c00327⟩
Accounts of Chemical Research, American Chemical Society, 2021, 54 (16), pp.3264. ⟨10.1021/acs.accounts.1c00327⟩
Accounts of Chemical Research, 2021, 54 (16), pp.3264. ⟨10.1021/acs.accounts.1c00327⟩
ConspectusAstatine (At) is the rarest on Earth of all naturally occurring elements, situated below iodine in the periodic table. While only short-lived isotopes (t1/2 ≤ 8.1 h) are known, 211At is the object of growing attention due to its emission
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::005ff8d17e3dbbaa494bd5d89663ca2a
https://doi.org/10.1021/acs.accounts.1c00327
https://doi.org/10.1021/acs.accounts.1c00327
Publikováno v:
Biomedical Sciences
Biomedical Sciences, Online ahead of print, 2021
HAL
Reference Module in Biomedical Sciences
Biomedical Sciences, Online ahead of print, 2021
HAL
Reference Module in Biomedical Sciences
International audience; Iodine and astatine radioisotopes are particularly attractive in nuclear medicine since their available isotopes cover all imaging and therapeutic modalities, from SPECT and PET imaging to beta, alpha and Auger electron therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64ee7a7b07691bfa460b38777c08630a
https://www.hal.inserm.fr/inserm-03332003
https://www.hal.inserm.fr/inserm-03332003
Publikováno v:
France, Patent n° : WO 2020/221744 A1. 2020
HAL
HAL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c55cc6de34f56aa7cc17ccd25f24e4c4
https://www.hal.inserm.fr/inserm-03013584
https://www.hal.inserm.fr/inserm-03013584
Publikováno v:
Pharmaceutics
Pharmaceutics, MDPI, 2021, 13 (6), pp.906. ⟨10.3390/pharmaceutics13060906⟩
Pharmaceutics, Vol 13, Iss 906, p 906 (2021)
Pharmaceutics, 2021, 13 (6), pp.906. ⟨10.3390/pharmaceutics13060906⟩
Pharmaceutics, MDPI, 2021, 13 (6), pp.906. ⟨10.3390/pharmaceutics13060906⟩
Pharmaceutics, Vol 13, Iss 906, p 906 (2021)
Pharmaceutics, 2021, 13 (6), pp.906. ⟨10.3390/pharmaceutics13060906⟩
Among all existing radionuclides, only a few are of interest for therapeutic applications and more specifically for targeted alpha therapy (TAT). From this selection, actinium-225, astatine-211, bismuth-212, bismuth-213, lead-212, radium-223, terbium
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::804017f515974f616e80edd5c25a9331
https://doi.org/10.3390/pharmaceutics13060906
https://doi.org/10.3390/pharmaceutics13060906
Autor:
Aurélia Roumesy, Cyrille Alliot, Yong-Sok Lee, Michel Chérel, François Guérard, Jean-François Gestin, Laurent Navarro, Martin W. Brechbiel
Publikováno v:
Bioorganic and Medicinal Chemistry
Bioorganic and Medicinal Chemistry, 2017, Epub ahead of print. ⟨10.1016/j.bmc.2017.09.022⟩
Bioorganic and Medicinal Chemistry, Elsevier, 2017, Epub ahead of print. ⟨10.1016/j.bmc.2017.09.022⟩
Bioorganic and Medicinal Chemistry, 2017, Epub ahead of print. ⟨10.1016/j.bmc.2017.09.022⟩
Bioorganic and Medicinal Chemistry, Elsevier, 2017, Epub ahead of print. ⟨10.1016/j.bmc.2017.09.022⟩
International audience; In this report we describe the development of an alternative approach to arylstannane chemistry for radiolabeling antibodies with radioiodine or astatine based on aryliodonium salts precursors. Bifunctional aryliodonium salts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd82eb2e0c53e0a0636473275c3de218
https://doi.org/10.1016/j.bmc.2017.09.022
https://doi.org/10.1016/j.bmc.2017.09.022
Autor:
Ferid Haddad, Jean-François Gestin, Michel Chérel, Laurent Navarro, Marion Berdal, François Guérard
Publikováno v:
HAL
TAT 11 INTERNATIONAL SYMPOSIUM
TAT 11 INTERNATIONAL SYMPOSIUM, Apr 2019, OTTAWA, Canada. pp.S29
TAT 11 INTERNATIONAL SYMPOSIUM
TAT 11 INTERNATIONAL SYMPOSIUM, Apr 2019, OTTAWA, Canada. pp.S29
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42be8620f9623fdd91e38b44c35f5a28
https://doi.org/10.1016/j.jmir.2019.11.094
https://doi.org/10.1016/j.jmir.2019.11.094
Autor:
François Guérard, Marion Berdal, Jean-François Gestin, Michel Chérel, Frédéric Pecorari, Laurent Navarro
Publikováno v:
Bioorganic and Medicinal Chemistry
Bioorganic and Medicinal Chemistry, In press, pp.167-174. ⟨10.1016/j.bmc.2018.11.034⟩
Bioorganic and Medicinal Chemistry, Elsevier, In press, pp.167-174. ⟨10.1016/j.bmc.2018.11.034⟩
Bioorganic and Medicinal Chemistry, In press, pp.167-174. ⟨10.1016/j.bmc.2018.11.034⟩
Bioorganic and Medicinal Chemistry, Elsevier, In press, pp.167-174. ⟨10.1016/j.bmc.2018.11.034⟩
International audience; 125I- and 211At-labeled azide and tetrazine (Tz) based prosthetic groups for bioorthogonal conjugation were designed and tested in a comparative study of five bioorthogonal systems. All five bioconjugation reactions conducted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01ceb840d88fedc55590d849bfff78d7
https://doi.org/10.1016/j.bmc.2018.11.034
https://doi.org/10.1016/j.bmc.2018.11.034